CHOP (C/EBP Homologous Protein), also known as DDIT3 (DNA Damage Inducible Transcript 3), is a key pro-apoptotic transcription factor that mediates endoplasmic reticulum (ER) stress-induced cell death. CHOP plays a central role in neurodegeneration by integrating ER stress, oxidative stress, and apoptotic signaling pathways. It is a critical executor of the unfolded protein response (UPR) when adaptive mechanisms fail, leading to cellular demise in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.
CHOP PROTEIN is a transcription factor of the C/EBP family that promotes apoptosis under conditions of severe ER stress. CHOP is induced by various cellular stresses including protein misfolding, calcium dysregulation, oxidative stress, and metabolic disturbances. Its upregulation is a hallmark of failed protein homeostasis in neurodegenerative diseases.
| Property | Value |
|----------|-------|
| Gene | DDIT3 (CHOP) |
| UniProt ID | Q9UHV9 |
| Molecular Weight | 19 kDa |
| Protein Class | Transcription factor (C/EBP family) |
| Subcellular Localization | Nucleus |
| Brain Expression | Low in normal brain, upregulated in disease |
| Chromosome | 12q24.1 |
CHOP has a characteristic structure:
- N-terminal Transactivation Domain: Regulates transcriptional activity
- Leucine Zipper (bZIP) Domain: Dimerization and DNA binding
- C-terminal Region: Contains regulatory sequences
- Serine/Threonine Sites: Phosphorylation modulates function
CHOP forms homodimers and heterodimers with other C/EBP family members to bind DNA and regulate gene expression.
CHOP is a key mediator of the UPR:
- Stress sensing: Activated by PERK, IRE1, and ATF6 branches of UPR
- Pro-apoptotic signaling: When adaptation fails, CHOP promotes apoptosis
- Transcriptional regulation: Controls genes involved in apoptosis and ER function
Under normal conditions, CHOP regulates:
- Protein folding capacity: Increases expression of ER chaperones
- Apoptosis: Pro-apoptotic signaling when stress is severe
- Autophagy: Links ER stress to autophagic degradation
- Metabolism: Affects lipid metabolism and cellular energy
CHOP is heavily involved in AD pathogenesis:
- Amyloid-beta effects: Aβ induces CHOP expression in neurons and glia
- ER stress: Aβ disrupts ER function, activating CHOP-mediated apoptosis
- Tau pathology: CHOP may interact with tau phosphorylation pathways
- Synaptic loss: CHOP activation contributes to synaptic degeneration
- Neuronal death: CHOP is upregulated in vulnerable brain regions
- Alpha-synuclein toxicity: CHOP is activated by α-syn aggregation
- Mitochondrial dysfunction: Links ER-mitochondrial apoptosis pathways
- Dopaminergic neuron vulnerability: CHOP contributes to SNc neuron loss
- Leucine-rich repeat kinase 2 (LRRK2): Interactions with CHOP pathway
- Protein aggregation: CHOP activated by misfolded SOD1, TDP-43, FUS
- ER stress: Prominent in motor neuron degeneration
- Astrocyte involvement: CHOP in non-neuronal cells
- Huntington's Disease: Mutant huntingtin induces CHOP expression
- Prion disease: CHOP activation in prion-infected neurons
- Stroke: CHOP in ischemic neuronal death
- Frontotemporal dementia: CHOP in TDP-43 pathology
The CHOP pathway offers therapeutic opportunities:
- ER stress modulators: TUDCA, sodium phenylbutyrate/taurursodiol
- CHOP inhibitors: Small molecule approaches in development
- UPR modulators: Targeting upstream PERK/IRE1 pathways
- Anti-apoptotic strategies: Blocking downstream CHOP effectors
- Dual roles: CHOP has some protective functions in early stress
- Cell-type specificity: Effects vary between neuron types
- Systemic toxicity: Broad ER stress inhibition may be harmful
CHOP as a disease biomarker:
- CSF CHOP: Elevated in AD and PD patients
- Blood cells: CHOP expression in peripheral mononuclear cells
- Postmortem brain: CHOP levels correlate with disease severity
| Protein |
Interaction Type |
Function |
| C/EBPβ |
Heterodimer |
DNA binding |
| ATF4 |
Co-activation |
Transcription |
| GADD34 |
Regulation |
PP1 cofactor |
| Bcl-2 family |
Regulation |
Apoptosis |
| PERK/IRE1 |
Upstream |
UPR signaling |
The study of Chop Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.